Literature DB >> 31415473

Persistent Neuroinflammation and Brain-Specific Immune Priming in a Novel Survival Model of Murine Pneumosepsis.

Scott J Denstaedt1, Joanna L Spencer-Segal2,3, Michael Newstead1, Klaudia Laborc3, Xianying Zeng1, Theodore J Standiford1, Benjamin H Singer1.   

Abstract

Pneumonia is the leading cause of sepsis and septic shock. Patients who survive pneumonia are vulnerable to long-term complications including increased risk of neurocognitive dysfunction. This study investigated the immune response and long-term complications of a non-surgical mouse model of Klebsiella pneumoniae pneumosepsis with antibiotic treatment. Pneumosepsis resulted in acutely enhanced expression of inflammatory cytokines, chemokines, and damage-associated molecular patterns in the brain and spleen. Despite resolution of infection, murine pneumosepsis survivors demonstrated a deficit in exploratory locomotor behavior at 2 weeks. This was associated with brain-specific persistent inflammatory gene expression and infiltrating myeloid cells in the brain. The brain inflammatory response was also primed in response to secondary challenge with lipopolysaccharide. The findings of this study demonstrate behavioral and inflammatory outcomes that parallel observations in other models of sepsis, but that have not previously been described in antibiotic-treated pneumonia models, highlighting a common pathway to the development of chronic brain dysfunction in sepsis survival.

Entities:  

Mesh:

Year:  2020        PMID: 31415473      PMCID: PMC7015772          DOI: 10.1097/SHK.0000000000001435

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.533


  45 in total

Review 1.  "Inflammatory" cytokines: neuromodulators in normal brain?

Authors:  L Vitkovic; J Bockaert; C Jacque
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

2.  Use of Animal Models in the Study of Inflammatory Mediators of Pneumonia.

Authors:  Borna Mehrad; Theodore J. Standiford
Journal:  ILAR J       Date:  1999

3.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

4.  Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.

Authors:  Vicente F Corrales-Medina; Karina N Alvarez; Lisa A Weissfeld; Derek C Angus; Julio A Chirinos; Chung-Chou H Chang; Anne Newman; Laura Loehr; Aaron R Folsom; Mitchell S Elkind; Mary F Lyles; Richard A Kronmal; Sachin Yende
Journal:  JAMA       Date:  2015-01-20       Impact factor: 56.272

5.  Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment.

Authors:  Graciela Andonegui; Erin L Zelinski; Courtney L Schubert; Derrice Knight; Laura A Craig; Brent W Winston; Simon C Spanswick; Björn Petri; Craig N Jenne; Janice C Sutherland; Rita Nguyen; Natalie Jayawardena; Margaret M Kelly; Christopher J Doig; Robert J Sutherland; Paul Kubes
Journal:  JCI Insight       Date:  2018-05-03

Review 6.  Animal models of human pneumonia.

Authors:  Joseph P Mizgerd; Shawn J Skerrett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

7.  Bidirectional relationship between cognitive function and pneumonia.

Authors:  Faraaz Ali Shah; Francis Pike; Karina Alvarez; Derek Angus; Anne B Newman; Oscar Lopez; Judith Tate; Vishesh Kapur; Anthony Wilsdon; Jerry A Krishnan; Nadia Hansel; David Au; Mark Avdalovic; Vincent S Fan; R Graham Barr; Sachin Yende
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

8.  Resolving postoperative neuroinflammation and cognitive decline.

Authors:  Niccolò Terrando; Lars I Eriksson; Jae Kyu Ryu; Ting Yang; Claudia Monaco; Marc Feldmann; Malin Jonsson Fagerlund; Israel F Charo; Katerina Akassoglou; Mervyn Maze
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

Review 9.  The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?

Authors:  Jonathan S Boomer; Jonathan M Green; Richard S Hotchkiss
Journal:  Virulence       Date:  2013-09-25       Impact factor: 5.882

Review 10.  Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.

Authors:  Scott J Denstaedt; Benjamin H Singer; Theodore J Standiford
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

View more
  5 in total

1.  lncRNA Neat1 regulates neuronal dysfunction post-sepsis via stabilization of hemoglobin subunit beta.

Authors:  Yan Wu; Pengfei Li; Liu Liu; Andrew J Goodwin; Perry V Halushka; Tetsuro Hirose; Shinichi Nakagawa; Jiliang Zhou; Meng Liu; Hongkuan Fan
Journal:  Mol Ther       Date:  2022-03-21       Impact factor: 12.910

Review 2.  Glucocorticoids and the Brain after Critical Illness.

Authors:  Alice R Hill; Joanna L Spencer-Segal
Journal:  Endocrinology       Date:  2021-03-01       Impact factor: 4.736

Review 3.  Cytokines in the Brain and Neuroinflammation: We Didn't Starve the Fire!

Authors:  Jan Pieter Konsman
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-25

4.  Long-term survivors of murine sepsis are predisposed to enhanced LPS-induced lung injury and proinflammatory immune reprogramming.

Authors:  Scott J Denstaedt; Angela C Bustamante; Michael W Newstead; Bethany B Moore; Theodore J Standiford; Rachel L Zemans; Benjamin H Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-23       Impact factor: 6.011

5.  Physiologic Effects of Exogenous Dextrose in Murine Klebsiella pneumoniae Sepsis Vary by Route of Provision.

Authors:  Byron Chuan; Lanping Guo; Bryce Cooper; Sagar Rawal; Teresa Gallego-Martin; Yingze Zhang; Bryan J McVerry; Christopher P O'Donnell; Faraaz Ali Shah
Journal:  Nutrients       Date:  2020-09-23       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.